Clinical study of MECT on 100 patients with refractory schizophrenia

OBJECTIVE: To investigate the MECT (MECT) clinical efficacy and safety of refractory schizophrenia (TRS) patients METHOD: Choose treated 200 patients with refractory schizophrenia patients were randomly divided into control group . the treatment group and control group with conventional therapy, the treatment group on the basis of conventional therapy with MECT treatment, treatment groups were compared: after 4 weeks of treatment treatment group PANSS scale score was significantly lower than the control group (P <0.05); the treatment group was 72%, the control group was 63% of the treatment group was significantly higher than the treatment group 2 patients developed short-term memory damage, and by reducing the dosage. after the frequency of treatment, in 3 to 5 days to resume normal control group patients No serious complications CONCLUSION: MECT treatment carried out on the basis of conventional drug treatment, the treatment of refractory schizophrenia is a safe and effective method.